Computation of Basic and Diluted Net Loss Per Common Share |
The following table presents the computation of basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(24,541 |
) |
|
$ |
(4,886 |
) |
|
$ |
(70,800 |
) |
|
$ |
(30,268 |
) |
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
36,991,650 |
|
|
|
36,202,496 |
|
|
|
36,810,878 |
|
|
|
35,924,413 |
|
Less: Weighted-average shares subject to repurchase |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Denominator for basic and diluted net loss per share attributable to common stockholders |
|
|
36,991,650 |
|
|
|
36,202,496 |
|
|
|
36,810,878 |
|
|
|
35,924,413 |
|
Basic and diluted net loss per share |
|
$ |
(0.66 |
) |
|
$ |
(0.13 |
) |
|
$ |
(1.92 |
) |
|
$ |
(0.84 |
) |
|
Effect of Anti-dilutive Securities |
The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Common stock options, restricted stock units and performance stock units |
|
|
11,058,562 |
|
|
|
10,635,480 |
|
|
|
10,909,888 |
|
|
|
10,484,633 |
|
Warrants to purchase common stock |
|
|
496,612 |
|
|
|
496,612 |
|
|
|
496,612 |
|
|
|
496,612 |
|
Common stock issuable in connection with convertible senior notes |
|
|
3,842,961 |
|
|
|
5,475,369 |
|
|
|
3,842,961 |
|
|
|
5,475,369 |
|
|
|
|
15,398,135 |
|
|
|
16,607,461 |
|
|
|
15,249,461 |
|
|
|
16,456,614 |
|
|